Satterley & Kelley PLLC
Know Your Rights. Call 800-655-2117For A Free Initial Consultation.

mesothelioma Archives

Defactinib ineffective for malignant pleural mesothelioma

A COMMAND Phase 2 trial of maintenance therapy using the drug defactinib has been found unable to increase the survival rate of patients with malignant pleural mesothelioma. This aggressive and incurable cancer has few treatment options to begin with; Louisville residents should know that the primary treatment is chemotherapy using a combination of the drugs pemetrexed and cisplatin.

A swallowing problem may indicate mesothelioma

A Kentucky resident experiencing problems swallowing may have an early sign indicating a cancer diagnosis of mesothelioma. Known as dysphagia, this type of symptom involving swallowing difficulties is not usually associated with asbestos-related illnesses. However, a Spanish medical journal recently published an article expressing the view that a swallowing problem could indicate the beginning stage of mesothelioma. There are two types of mesothelioma: pleural mesothelioma affects the lungs, and peritoneal mesothelioma affects the abdomen.

Systemic inflammation shortens lives of mesothelioma patients

Mesothelioma, as Louisville residents may know, is an aggressive cancer usually caused by long-term exposure to asbestos. Among mesothelioma patients, there are several factors that can determine how long they have to live, and Chinese researchers have recently pointed to systemic inflammation as one of those factors. Their results were published in Cancer Management and Research.

FDA approves first mesothelioma treatment in 15 years

Louisville residents should know that mesothelioma is a rare and aggressive form of cancer often found in those who have been exposed to asbestos over a long period of time. In May of 2019, the Food and Drug Administration approved of the first new treatment for mesothelioma in 15 years.

Jury holds J&J responsible in mesothelioma case

While many Louisville residents may think only of longtime workers in the asbestos industry when they consider the rare cancer called mesothelioma, one recent verdict points to a far more common risk. Johnson & Johnson, the large pharmaceutical and personal-care products corporation, was ordered to pay $25 million to one woman who sued the company after developing mesothelioma. She said that the malignancy was caused by her daily use of talc-based products produced by the company, particularly J&J Baby Powder and Shower to Shower.

Many elderly mesothelioma patients die without treatment

Mesothelioma specialists have conducted a study that may be of interest to those in Louisville who know someone with this cancer. Results of the study have been published in the Annals of Surgical Oncology revealing that many mesothelioma patients 80 years and older are dying without receiving any cancer-related treatments. These treatments could have increased the median survival rate, which came to only 4.1 months.

How radiotherapy may extend the life of mesothelioma patients

The European Society for Radiotherapy and Oncology held its annual ESTRO 38 conference, during which a study was presented that may intrigue mesothelioma patients in Louisville. The study found that radiotherapy, which has been used to control the symptoms of mesothelioma, may actually do much more that is positive for patients.

Mesothelioma risk persists long after asbestos exposure

Workers in Louisville who were exposed to asbestos continue to suffer a risk for mesothelioma that does not decline despite stopping the exposure. In many cases, ending exposure to a carcinogen lowers the risk of a cancer diagnosis, as in the case of quitting smoking. Mesothelioma is a rare cancer that is generally caused by asbestos exposure. In most cases, it is linked to exposure in the workplace. Because the mineral was not flammable, did not corrode and provided strong insulation, it was mined and used in pipes, insulation and a range of industrial activities.

Chemotherapy ineffective on some types of metastatic mesothelioma

Louisville residents may be familiar with mesothelioma, a cancer caused usually by exposure to asbestos. The most common type is pleural mesothelioma, which affects the lining of the lungs. This type can be divided into three subtypes. Normally, chemotherapy is used to treat pleural mesothelioma, but new research finds some of these subtypes do not respond so well to the treatment.

CAR T-cell therapy may prove effective in treating mesothelioma

Louisville residents may want to know about a new form of immunotherapy that has been shown to be effective in treating malignant pleural mesothelioma. CAR T-cell therapy involves a laboratory reprogramming of a patient's T cells, a certain type of white blood cell, so that they attack a surface protein in the cancer called mesothelin.

You do not have to stand alone. Call 855-385-9532 to talk to a lawyer at Satterley & Kelley PLLC in Louisville.

Office Address

8700 Westport Road
Suite 202
Louisville, KY 40242

Toll Free: 800-655-2117
Toll Free: 855-385-9532
Phone: 502-785-8758
Fax: 502-814-5500
Louisville Law Office Map

Office Numbers

Email Us For A Response

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy